Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 42% ± 18% |
Insufficient scRNA-seq data for expression of NR1I2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 92% | 1809.28 | 890 / 966 | 86% | 20.07 | 454 / 527 |
liver | 100% | 6745.55 | 226 / 226 | 76% | 13.33 | 308 / 406 |
pancreas | 97% | 27.61 | 317 / 328 | 59% | 7.01 | 105 / 178 |
stomach | 81% | 25.91 | 290 / 359 | 73% | 17.16 | 210 / 286 |
adrenal gland | 98% | 50.03 | 252 / 258 | 3% | 0.06 | 6 / 230 |
spleen | 100% | 61.31 | 241 / 241 | 0% | 0 | 0 / 0 |
kidney | 97% | 31.10 | 86 / 89 | 1% | 0.05 | 6 / 901 |
ovary | 87% | 24.83 | 157 / 180 | 6% | 0.19 | 27 / 430 |
thymus | 93% | 23.90 | 610 / 653 | 0% | 0 | 0 / 605 |
lung | 79% | 15.96 | 456 / 578 | 12% | 1.20 | 137 / 1155 |
bladder | 62% | 7.10 | 13 / 21 | 24% | 5.67 | 121 / 504 |
prostate | 84% | 14.71 | 206 / 245 | 0% | 0 | 0 / 502 |
brain | 80% | 26.93 | 2111 / 2642 | 0% | 0.00 | 1 / 705 |
esophagus | 40% | 6.23 | 575 / 1445 | 32% | 3.56 | 59 / 183 |
breast | 63% | 16.19 | 287 / 459 | 1% | 0.02 | 6 / 1118 |
uterus | 50% | 8.34 | 85 / 170 | 2% | 0.30 | 10 / 459 |
adipose | 50% | 7.63 | 605 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 49% | 47.43 | 456 / 929 | 0% | 0 | 0 / 0 |
heart | 48% | 6.58 | 415 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 45% | 5.95 | 602 / 1335 | 0% | 0 | 0 / 0 |
skin | 23% | 5.45 | 419 / 1809 | 2% | 0.07 | 8 / 472 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.37 | 4 / 29 |
muscle | 3% | 0.29 | 21 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0042908 | Biological process | xenobiotic transport |
GO_0042178 | Biological process | xenobiotic catabolic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0008202 | Biological process | steroid metabolic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0045111 | Cellular component | intermediate filament cytoskeleton |
GO_0016604 | Cellular component | nuclear body |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR1I2 |
Protein name | Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR) Nuclear receptor subfamily 1 group I member 2 (Nuclear receptor subfamily 1, group I, member 2, isoform CRA_c) Orphan nuclear receptor PXR Nuclear receptor subfamily 1 group I member 2 (Nuclear receptor subfamily 1, group I, member 2, isoform CRA_a) Pregnane X nuclear receptor Nuclear receptor subfamily 1, group I, member 2, isoform CRA_b (Pregnane X nuclear receptor variant 2) PAR2 |
Synonyms | NR1i2 hCG_21777 PXR |
Description | FUNCTION: Nuclear receptor that binds and is activated by variety of endogenous and xenobiotic compounds. Transcription factor that activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs and endogenous compounds. Activated by the antibiotic rifampicin and various plant metabolites, such as hyperforin, guggulipid, colupulone, and isoflavones. Response to specific ligands is species-specific. Activated by naturally occurring steroids, such as pregnenolone and progesterone. Binds to a response element in the promoters of the CYP3A4 and ABCB1/MDR1 genes. . |
Accessions | ENST00000337940.4 [O75469-7] J3KPQ3 O75469 ENST00000466380 ENST00000393716.8 [O75469-1] H0Y8E2 Q9H4M8 ENST00000393716 ENST00000466380.6 [O75469-4] B6ZGT1 F1DAL3 F1D8P9 |